PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Operating Income (2021 - 2026)

PepGen (PEPG) posted Operating Income of -$18.9 million for Q1 2026, up 3.87% sequentially from -$19.7 million in Q4 2025, and up 39.52% YoY from -$13.6 million in Q1 2025.

Analysis

PepGen (PEPG) Operating Income (2021 - 2026) Analysis & Trends

PepGen has reported Operating Income for 6 years, with the latest figure at -$18.9 million in Q1 2026.

  • Quarterly Operating Income rose 39.52% year-over-year to -$18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$81.2 million (up 25.65% YoY) and the FY2025 annual result came in at -$93.6 million, up 4.22% from the prior year.
  • Operating Income advanced to -$18.9 million in Q1 2026 per PEPG's latest filing, from -$19.7 million in the prior quarter.
  • Over five years, Operating Income peaked at -$13.9 million in Q1 2022 and troughed at -$31.3 million in Q1 2025.
  • A 5-year average of -$21.4 million and a median of -$19.8 million in 2024 frame the typical range for Operating Income.
  • The sharpest annual moves came in 2022 and 2026: Operating Income tumbled 239.77% in 2022, then surged 39.52% in 2026.
  • Over 5 years, Operating Income stood at -$17.2 million in 2022, then retreated by 20.9% to -$20.8 million in 2023, then dropped by 16.98% to -$24.3 million in 2024, then rose by 19.06% to -$19.7 million in 2025, then rose by 3.87% to -$18.9 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$18.9 million, -$19.7 million, and -$18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 PepGen 217.99 Mn 217.99 Mn - -18.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.94 Mn
Mar 31, 2026 -18.94 Mn
Dec 31, 2025 -19.71 Mn
Sep 30, 2025 -18.65 Mn
Jun 30, 2025 -23.93 Mn
Mar 31, 2025 -31.32 Mn
Dec 31, 2024 -24.35 Mn
Sep 30, 2024 -23.17 Mn
Jun 30, 2024 -30.43 Mn
Mar 31, 2024 -19.80 Mn
Dec 31, 2023 -20.81 Mn
Sep 30, 2023 -24.78 Mn
Jun 30, 2023 -21.14 Mn
Mar 31, 2023 -18.03 Mn
Dec 31, 2022 -17.21 Mn
Sep 30, 2022 -19.55 Mn
Jun 30, 2022 -17.64 Mn
Mar 31, 2022 -13.89 Mn
Dec 31, 2021 -7.21 Mn
Sep 30, 2021 -8.08 Mn